The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention

机译：降脂治疗在经皮冠状动脉介入治疗患者的二级预防中的应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDRecent literature suggests that lipid-lowering therapy may have an early beneficial effect among patients undergoing percutaneous coronary intervention (PCI) because the therapy decreases cardiac mortality, morbidity and possibly restenosis.

机译：背景技术最近的文献表明，降脂疗法可能在接受经皮冠状动脉介入治疗（PCI）的患者中具有早期有益效果，因为该疗法降低了心脏死亡率，发病率并可能降低了再狭窄。

著录项

期刊名称 The Canadian Journal of Cardiology
作者
Jessica M Ma; Cynthia A Jackevicius; Uchenwa Genus; Vladimir Dzavik;
展开▼
作者单位

展开▼
年(卷),期 2006(22),5
年度 2006
页码 419–423
总页数 5
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Angioplasty Cholesterol Drugs Hypercholesterolemia Lipids;

机译：血管成形术;胆固醇;药物;高胆固醇血症;脂质;

相似文献

外文文献
中文文献
专利

1. The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention. [J] . Ma JM, Jackevicius CA, Genus U, The Canadian journal of cardiology . 2006,第5期

机译：降脂治疗在接受经皮冠状动脉介入治疗的患者中的二级预防应用。
2. Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention [J] . Yun-Yan Dai, Hai-Shan Zhang, Xin-Gang Zhang, Journal of Thoracic Disease . 2017,第5期

机译：在经皮冠状动脉介入的急性冠状动脉综合征患者中，他汀类欧替米贝对他汀类血脂降低治疗
3. Unique referral system contributes to long-term net clinical benefits in patients undergoing secondary prevention therapy after percutaneous coronary intervention [J] . Shigetaka Kageyama, Koichiro Murata, Ryuzo Nawada, PLoS One . 2020,第11期

机译：独特的转诊系统在经皮冠状动脉干预后进行二次预防治疗的患者有助于长期净临床益处
4. Influence of Diabetes Mellitus in patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions: Multicenter PCI Registry in Japan [C] . E. Saito, M. Hirose, T. Miyauchi, International Congress on Coronary Artery Disease . 2003

机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention [O] . Yun-Yan Dai, Hai-Shan Zhang, Xin-Gang Zhang, 2017

机译：他汀-依泽替米贝与他汀类降脂治疗在经皮冠状动脉介入治疗的急性冠脉综合征患者中的应用
7. The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention [O] . Ma, Jessica M, Jackevicius, Cynthia A, Genus, Uchenwa, 2006

机译：降脂治疗在经皮冠状动脉介入治疗患者的二级预防中的应用

The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention

摘要

著录项

相似文献

相关主题

期刊订阅